Abivax SA Sponsored ADR (2X10)
XDUS
Real-time Data
06:00 AM
Day's Range
83.5052 wk Range
63.00Overview - 2X10 - Abivax SA Sponsored ADR
Key Statistics
Valuation
Enterprise Value
-514.82M
P/E (Trailing)
‪-18.94‬
PEG Ratio
‪0.71‬
Price / Book
‪16.81‬
EV / EBITDA
‪1.91‬
Profitability
Return on Assets
‪-57.51%‬
Return on Equity
‪-73.83%‬
Ownership
Shares Outstanding
79.29M
Price stats
50-Day Avg
‪107.20‬
200-Day Avg
‪102.64‬
Peers - 2X10 - Abivax SA Sponsored ADR
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- 2X10XDUSAbivax SA Sponsored ADR+22.95%52-week change-18.94P/E (Trailing)—Profit Margin
- 0QFXDUSModerna Inc.+85.69%52-week change—P/E (Trailing)—Profit Margin
- 0MEXDUSTwist Bioscience Corporation+84.27%52-week change-112.23P/E (Trailing)‪50.72%‬Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+82.13%52-week change-37.88P/E (Trailing)—Profit Margin
- 2LBXDUSIovance Biotherapeutics Inc.+80.83%52-week change-8.43P/E (Trailing)‪34.27%‬Profit Margin
- 42ZXDUSRevolution Medicines, Inc.+78.13%52-week change-30.44P/E (Trailing)—Profit Margin
- 3O8XDUSOmeros Corp.+77.85%52-week change-333.00P/E (Trailing)—Profit Margin
Profile Summary - 2X10 - Abivax SA Sponsored ADR
About
Abivax SA Sponsored ADR is a biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to help stabilize the immune response in chronic inflammatory diseases. The company’s lead program centers on obefazimod, a clinical-stage candidate being studied for inflammatory…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
